SOBI:STO
Swedish Orphan Biovitrum AB (publ)
498,20Â SEK
arrow_upward
+0,93%(+4,60) 1D
6 nën, 5:29:36 m.d., GMT+1 · SEK
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për SOBI...
Hap
483,00Â SEK
I lartë
498,20Â SEK
I ulët
479,00Â SEK
Kapitalizimi i tregut
178,17Â mld
Vëllimi mesatar
341,57 mijë
Vëllimi
563,09 mijë
Raporti çmim/fitim
26,46
Maksimumi 52-javor
498,20Â SEK
Minimumi 52-javor
314,40Â SEK
Fitimet për aksion
18,83Â SEK
Aksionet në qarkullim
357,64Â mln
Numri i punonjësve
2 mijë
Hap
483,00Â SEK
I lartë
498,20Â SEK
I ulët
479,00Â SEK
Kapitalizimi i tregut
178,17Â mld
Vëllimi mesatar
341,57 mijë
Vëllimi
563,09 mijë
Raporti çmim/fitim
26,46
Maksimumi 52-javor
498,20Â SEK
Minimumi 52-javor
314,40Â SEK
Fitimet për aksion
18,83Â SEK
Aksionet në qarkullim
357,64Â mln
Numri i punonjësve
2 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Investor's Business Daily
·
36 minuta më parë
Futures Loom; Nvidia Probes CEO Huang Espionage Reports
Cryptonews.net
·
42 minuta më parë
XRP Price Prediction: Analyst Warns of $0.80 Crash if S&P 500 Breaks Key Support
Yahoo Finance
·
1 ditë më parë
Tech stocks are now cheaper than the S&P 500 for the first time since 2017 — here's what history says comes next: Chart of the Day
Bloomberg
·
1 ditë më parë
Wall Street Strategists Call Stock Rout a Fresh Reason to Buy
Profili
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Rreth Swedish Orphan Biovitrum AB (publ)
Drejtori ekzekutivGuido Oelkers
Punonjësit2,21 mijë
Themeluar më1939
Selia-
SektoriHealth Care
Industria-
Uebsajtisobi.com